hrp0098p3-38 | Bone, Growth Plate and Mineral Metabolism | ESPE2024

Burosumab Effectiveness on Pediatric Patients with X-Linked Hypophosphatemic Rickets: A Prospective Single-Center Study

Aletani Lujain , Alsagheir Afaf , Aljaser Alhanouf , Alhuthil Raghad , Alghamdi Nujud , Alturki Haifa

Background: Traditionally patients with X-linked Hypophosphatemic Rickets (XLH) have been treated with conventional therapy, however, in 2018, the FDA approved Burosumab use in XLH patients.Objective: To investigate Burosumab effectiveness on pediatric patients with XLH by observing an improvement in serum phosphorus concentration and total rickets severity score (RSS) within 12 months period.<stro...

hrp0098p2-332 | Late Breaking | ESPE2024

Familial Hypercholesterolemia in Saudi Arabia: Clinical Characteristics and Mortality Rate

Alsagheir Afaf , Albitar Mohammed , Alansari Rahaf , Aljaser Alhanouf , Ali Anas , Aldamouni Maeen , Alhosainy Ziad , Mohamed Rojina , Jaamour Heba , Alhuthil Raghad , Al-hamoudi Saad , Aldayel Abdulaziz , Abdullah Ismail , Aljumaa Mohammad , Khamaj Yara , Mcrabi Ali , Alquayt Meshari

Background: Familial Hypercholesterolemia (FH) increases the risk of atherosclerosis, leading to early cardiovascular disease (CVD) and death at a younger age. Therefore, this study aims to describe the clinical characteristics of FH patients, assess the outcome of adopting reverse cascade screening, and describe the complications and rate of mortality in FH cases followed at our center.Methods & Materials: This is a...